Pu Li

2.2k citations

52 papers · 1.7k · h-index 24

Impact in

Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing

Papers in

Molecular Biology 35
- Circular RNAs in diseases 9
- RNA modifications and cancer 7
- RNA Research and Splicing 5
- Epigenetics and DNA Methylation 4
Cancer Research 28
- MicroRNA in disease regulation 21
- Cancer-related molecular mechanisms research 12

Co-authors: Xuehua Chen (16 shared papers)Zhenggang Zhu (9 shared papers)Bingya Liu (7 shared papers)Liping Su (6 shared papers)Qu Cai (5 shared papers)Hua Tang (2 shared papers)Beiqin Yu (4 shared papers)Changjun Yin (7 shared papers)
Journals: Journal of Translational Medicine (7 papers)Biomedicine & Pharmacotherapy (5 papers)Oncotarget (4 papers)PLoS ONE (3 papers)Cancer Letters (2 papers)
Partner nations: China United States Qatar

In The Last Decade

Pu Li

52 papers receiving 1.7k citations

Peers

Countries citing papers authored by Pu Li

Since Specialization

Citations

This map shows the geographic impact of Pu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pu Li more than expected).

Fields of papers citing papers by Pu Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pu Li. The network helps show where Pu Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Pu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pu Li Line = papers co-authored together Pu Li links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment Cell Research ·Pu Li, Jingxuan Shan, Xue-Hua Chen, Di Zhang, Li-Ping Su, Xiu-ying Huang, Bei-Qin Yu, Qiao-Ming Zhi, Cheng-Long Li, Ya-Qing Wang, Sara Tomei, Qu Cai, Jun Ji, Jian-Fang Li, Lotfi Chouchane, Yingyan Yu, Fang-Zhen Sun, Zhiheng Xu, Bingya Liu, Zhenggang Zhu	2015	144
2	MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF Biomedicine & Pharmacotherapy ·Junqing Wang, Liping Su, Xuehua Chen, Pu Li, Qu Cai, Beiqin Yu, Bingya Liu, Weize Wu, Zhenggang Zhu	2014	141
3	MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells Cancer Letters ·Mei-Jing Long, Fuxia Wu, Pu Li, Min Liu, Xin Li, Hua Tang	2012	122
4	Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species Toxicology Letters ·Jin Zhou, Pu Li, Xiaofeng Xue, Songbing He, Yuting Kuang, Hong Zhao, Shaoji Chen, Qiaoming Zhi, Xiaobo Guo	2013	90
5	Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer Cancer Letters ·Xiongyan Wu, Xuehua Chen, Quan Zhou, Pu Li, Beiqin Yu, Jianfang Li, Ying Qu, Jun Yan, Yingyan Yu, Min Yan, Zhenggang Zhu, Bingya Liu, Liping Su	2013	84
6	Genetic Variants in miRNAs Predict Bladder Cancer Risk and Recurrence Cancer Research ·Meilin Wang, Haiyan Chu, Pu Li, Lin Yuan, Guangbo Fu, Lan Ma, Danni Shi, Dongyan Zhong, Na Tong, Chao Qin, Changjun Yin, Zhengdong Zhang	2012	73
7	miR‐152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines The Prostate ·Chen Zhu, Jie Li, Qi Ding, Gong Cheng, Hai Zhou, Liangjun Tao, Hongzhou Cai, Pu Li, Qiang Cao, Xiaobing Ju, Xiaoxin Meng, Chao Qin, Lixin Hua, Pengfei Shao, Changjun Yin	2013	67
8	NF-κB-modulated miR-130a targets TNF-α in cervical cancer cells Journal of Translational Medicine ·Jian Zhang, Haidong Wu, Pu Li, Yanzheng Zhao, Min Liu, Hua Tang	2014	63
9	Epigenetic Silencing of miR-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IP PLoS ONE ·Pu Li, Xuehua Chen, Liping Su, Chenglong Li, Qiaoming Zhi, Beiqin Yu, Hong Sheng, Junqing Wang, Runhua Feng, Qu Cai, Jianfang Li, Yingyan Yu, Min Yan, Bingya Liu, Zhenggang Zhu	2013	63
10	miR-134 Functions as a Tumor Suppressor in Cell Proliferation and Epithelial-to-Mesenchymal Transition by Targeting KRAS in Renal Cell Carcinoma Cells DNA and Cell Biology ·Yiyang Liu, Mingcong Zhang, Jian Qian, Meiling Bao, Xiaoxin Meng, Shaobo Zhang, Lei Zhang, Ruizhe Zhao, Shuang Li, Qiang Cao, Pu Li, Xiaobing Ju, Qiang Lü, Jie Li, Pengfei Shao, Chao Qin, Changjun Yin	2015	58
11	miR-154 inhibits prostate cancer cell proliferation by targeting CCND2 Urologic Oncology Seminars and Original Investigations ·Chen Zhu, Pengfei Shao, Meiling Bao, Pu Li, Hai Zhou, Hongzhou Cai, Qiang Cao, Liangjun Tao, Xiaoxin Meng, Xiaobing Ju, Chao Qin, Jie Li, Changjun Yin	2013	51
12	Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells Cell Death and Differentiation ·Konduru S. Sastry, Mariam Al-Muftah, Pu Li, Moza Khalifa Alkowari, E Wang, Aouatef Ismail Chouchane, Dhanya Kizhakayil, George Kulik, Francesco M. Marincola, Abdelali Haoudi, Lotfi Chouchane	2014	48
13	Targeting Wnt/EZH2/microRNA-708 signaling pathway inhibits neuroendocrine differentiation in prostate cancer Cell Death Discovery ·Jingxuan Shan, Mariam Al-Muftah, Moza Khalifa Alkowari, Sirin W. J. Abuaqel, Khalid Al‐Rumaihi, Issam Al‐Bozom, Pu Li, Lotfi Chouchane	2019	48
14	Genetic Variation in DROSHA 3’UTR Regulated by hsa-miR-27b Is Associated with Bladder Cancer Risk PLoS ONE ·Yuan Lin, Haiyan Chu, Meilin Wang, Xiaojian Gu, Danni Shi, Lan Ma, Dongyan Zhong, Mulong Du, Pu Li, Na Tong, Guangbo Fu, Chao Qin, Changjun Yin, Zhengdong Zhang	2013	44
15	A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population Mutagenesis ·Shaobo Zhang, Jian Qian, Qiang Cao, Pu Li, Meilin Wang, Jian Wang, Xiaobing Ju, Xiaoxin Meng, Qiang Lü, Pengfei Shao, Zhengdong Zhang, Chao Qin, Changjun Yin	2014	43
16	CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126 Chemico-Biological Interactions ·Junqing Wang, Xuehua Chen, Pu Li, Liping Su, Beiqin Yu, Qu Cai, Jianfang Li, Yingyan Yu, Bingya Liu, Zhenggang Zhu	2013	40
17	A Genetic Variant in pre-miR-27a Is Associated with a Reduced Renal Cell Cancer Risk in a Chinese Population PLoS ONE ·Danni Shi, Pu Li, Lan Ma, Dongyan Zhong, Haiyan Chu, Yan Fu, Qiang Lv, Chao Qin, Wei Wang, Meilin Wang, Na Tong, Zhengdong Zhang, Changjun Yin	2012	38
18	miRNA-154-5p Inhibits Proliferation, Migration and Invasion by Targeting E2F5 in Prostate Cancer Cell Lines Urologia Internationalis ·Yang Zheng, Zhu Chen, Long Ma, Pengfei Shao, Chao Qin, Pu Li, Qiang Cao, Xiaobing Ju, Gong Cheng, Qingyi Zhu, Xiao-Jian Gu, Lixin Hua	2016	36
19	LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: A meta-analysis Clinics and Research in Hepatology and Gastroenterology ·Ye Han, Xiaofeng Xue, Min Jiang, Xiaobo Guo, Pu Li, Fei Liu, Bin Yuan, Yichen Shen, Xingpo Guo, Qiaoming Zhi, Hong Zhao	2014	34
20	NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer Biomedicine & Pharmacotherapy ·Ye Han, Yuting Kuang, Xiaofeng Xue, Xiaobo Guo, Pu Li, Xu Wang, Xingpo Guo, Bin Yuan, Qiaoming Zhi, Hong Zhao	2014	34

About Pu Li

Pu Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Surgery, having authored 52 papers that have together received 1.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (9 papers), Cancer Cells and Metastasis (8 papers), RNA modifications and cancer (7 papers), RNA Research and Splicing (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Cancer Research (997 citations), Molecular Biology (1.3k citations), Oncology (330 citations), Immunology (173 citations) and Cell Biology (82 citations). Pu Li has collaborated with scholars based in China, United States and Qatar. Frequent co-authors include Xuehua Chen, Zhenggang Zhu, Bingya Liu, Liping Su, Qu Cai, Hua Tang, Beiqin Yu, Changjun Yin, Qiaoming Zhi and Chao Qin. Their work appears in journals such as Journal of Translational Medicine, Biomedicine & Pharmacotherapy, Oncotarget, PLoS ONE and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Pu Li

Impact in

Papers in i

In The Last Decade

Pu Li

Peers

Countries citing papers authored by Pu Li

Fields of papers citing papers by Pu Li

All Works

About Pu Li

Explore authors with similar magnitude of impact

Papers in